Rensselaer Polytechnic Institute Announces Dr. Francis S. Collins, Acting Science Advisor to President Joe Biden, and Dr. Richard N. Haass, President of the Council on Foreign Relations, To Receive Honorary Doctorates at 2022 Commencement on May 21

Rensselaer Polytechnic Institute President Shirley Ann Jackson announced that Dr. Francis S. Collins, Acting Science Advisor to President Joe Biden, and Dr. Richard N. Haass, President of the Council on Foreign Relations, will receive honorary doctorates at the Institute’s 216th Commencement on Saturday, May 21.

Rensselaer Polytechnic Institute Launches Series Where BioArt and Biotechnology Merge

Kathy High, Professor of Video and New Media at Rensselaer, has created an online series to explore the intersection of bioArt and biotechnology. In collaboration with the Center for Biotechnology and Interdisciplinary Studies, the Arts department and the School of Humanities, Arts, and Social Sciences, and NATURE Lab, a project of The Sanctuary for Independent Media, the one-hour lunchtime presentations, BioArt Talks @CBIS, will begin on March 25.

Spring Career Fair Provided Opportunities for Arch Away Experiences

In an effort to support over 1,400 students for the third complement of Arch away opportunities following the summer of 2022, the Center for Career and Professional Development (CCPD) at Rensselaer Polytechnic Institute continues to engage and build partnerships with top industry employers.

Medicinal Chemist Christopher L. Cioffi Joins Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute has named medical chemist Christopher L. Cioffi as its Thomas and Constance D’Ambra Professor of Medicinal Organic Chemistry. As a doctoral student in the laboratory of Mark Wentland at Rensselaer Polytechnic Institute, Dr. Cioffi, B.S. ’94 and Ph.D. ’00, witnessed the birth of Samidorphan, a compound that is now part of the FDA-approved schizophrenia treatment Lybalvi.

Back to top